Market Overview

Mid-Day Market Update: Essendant Rises After Q2 Results; Tonix Pharmaceuticals Shares Plunge


Midway through trading Friday, the Dow traded up 0.10 percent to 25,553.06 while the NASDAQ declined 0.72 percent to 7,795.41. The S&P also fell, dropping 0.23 percent to 2,830.94.

Leading and Lagging Sectors

On Friday, the telecommunication services shares climbed 1.94 percent. Meanwhile, top gainers in the sector included Globalstar, Inc. (NYSE: GSAT) up 6 percent, and BT Group plc (NYSE: BT) up 6 percent.

In trading on Friday, information technology shares fell 1 percent.

Top Headline

Twitter Inc (NYSE: TWTR) shares fell around 17 percent in reaction to second-quarter results.

MAUs totaled 335 million, with 267 million accounted for by international customers and 68 million by U.S. customers. The year-over-year increase was 9 million, but the figure was down 1 million from Q1. Average daily active users climbed 11 percent, faster than the 10-percent growth in Q1, extending the streak of double-digit year-over-year growth to seven quarters.

The social networking platform reported non-GAAP earnings per share of 17 cents in Q2 compared to 8 cents per share one year ago. Twitter's quarterly revenue rose 24 percent year-over-year to $711 million. Analysts, on average, estimated EPS of 17 cents per share on revenues of $696.23 million.

Equities Trading UP

World Fuel Services Corporation (NYSE: INT) shares shot up 21 percent to $27.07 as the company posted better-than-expected Q2 results.

Shares of Endava Ltd (NYSE: DAVA) got a boost, shooting up 26 percent to $25.13 after pricing its IPO at $20 per share.

Essendant Inc. (NASDAQ: ESND) shares were also up, gaining 15 percent to $15.12 after reporting upbeat Q2 results.

Equities Trading DOWN

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares dropped 67 percent to $1.3099 in reaction to a disappointing update relating to a clinical trial. The company said it will stop a Phase 3 study of its Tonmya therapy in military-related posttraumatic stress disorder due to inadequate separation from placebo on the primary endpoint at week 12.

Shares of American Midstream Partners, LP (NYSE: AMID) were down 42 percent to $6.7165 after the company reported a revised capital allocation strategy and distribution cut from $0.4125 per unit to $0.1031 per unit.

Cellectar Biosciences, Inc. (NASDAQ: CLRB) was down, falling around 37 percent to $3.44. Cellectar Biosciences priced its public offering for gross proceeds of $14.4 million.


In commodity news, oil traded down 0.56 percent to $69.22 while gold traded down 0.18 percent to $1,233.10.

Silver traded up 0.13 percent Friday to $15.515, while copper fell 0.05 to $2.8165.


European shares were higher today. The eurozone’s STOXX 600 climbed 0.35 percent, the Spanish Ibex Index rose 0.91 percent, while Italy’s FTSE MIB Index rose 0.29 percent. Meanwhile the German DAX climbed 0.41 percent, and the French CAC 40 rose 0.46 percent while U.K. shares rose 0.55 percent.


The U.S. economy expanded at an annual rate of 4.1 percent for the second quarter, compared to a revised 2.2 percent rate in the prior quarter.

The University of Michigan's consumer sentiment index rose to 97.90 for July, versus prior reading of 97.10. Economists were expecting a reading of 97.10.

The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.

Posted-In: Mid-Day Market UpdateNews Eurozone Commodities Global Intraday Update Markets


Related Articles (BT + AMID)

View Comments and Join the Discussion!

MoviePass Experiencing Service Interruption, Helios And Matheson Continues Fall

A Fairy-Tale Ending: Disney, Fox Shareholders Approve Merger